Mo1207 Discrepancy Between Fecal Biomarkers and Their Intestinal Gene Expression in Ulcerative Colitis: Results From an Anti-IL-13 Antibody Study
Walter Reinisch(Medical University of Vienna), Fabio Cataldi(Pfizer (United States)), Sunil Khurana, Julián Panés(Hospital Clínic de Barcelona), Gail M. Comer(Pfizer (United States)), Fei Hua(Soochow University), Michelle Hinz(Pfizer (United States)), Karen Page(Pfizer (United States)), Tara McDonnell Moorehead(Clinical Solutions)
Cited by 1
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775